基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Because of the highly contagious nature of the SARS-Coronavirus (CoV),a rapid and reliable diagnostic test is urgently needed for making a definite diagnosis at early phase so that infected individuals can be isolated while avoiding blanket quarantines and the unnecessary burden on the medical care system.Unfortanantly,current kits/procedures had only less than 20 % positive detecting rate with serum or other samples of real SARS patients.Due to the compositions varies with times and individuals,the septum and lung lavage are impossible to serve as a standardized sample source for the comparison or monitoring of viral load.Therefore,the currently available kits/procedures should be improved and a good sample source should be identified.[Methods] Viral RNA in two hundred microlitter plasma or one million lymphocytes from SARS patients were extracted with Trizol,and then entire RNA was used as a template in a modified procedure of RT-PCR.CoV viral load was quantified in 45 patients at different phases of SARS infection and compared between the paired samples of plasma and lymphocytes obtained from 5 patients who had recovered from SARS for 2 months and lived in a normal life.[Results] Our methods detected CoV at a level of a few copies with 60-80% positive detection rate for plasma from SARS patients within 1 to 7 days after fever,which was much more sensitive than other current available method(positive rate at 8%~20%).The mean viral copies in 17 acute phase patients(1 to 7 days after fever)was 8,951,while that in 18 sub-acute phase patients(13 to 36 days after fever)was 98 and that in 10 recovered patients(79 to 91 days after fever)was 88.Importantly,the levels of CoV in lymphocytes of 5 patients who had recovered from SARS for 2 months were 2 to 3 orders of magnitude higher than that in the plasma.[Conclusions] The early and definite diagnosis of SARS can be achieved by our modified RT-PCR.CoV load peaked during the acute phase and rapidly dropped in sub-acute and recovery phases.The lymphocytes may be the targets or reservoir for CoV and are the best sample source for early SARS diagnosis and the monitoring of CoV infections.
推荐文章
新型冠状病毒肺炎患者血常规及淋巴细胞亚群的变化特点
肺炎,病毒性
新型冠状病毒肺炎
新型冠状病毒
淋巴细胞
CD4阳性T淋巴细胞
血常规
SARS冠状病毒IgG的ELISA检测方法建立
SARS冠状病毒
IgG抗体
酶联免疫吸附试验ELISA
T淋巴细胞亚群在新型冠状病毒肺炎诊疗中的临床意义
新型冠状病毒肺炎
新型冠状病毒
免疫
T淋巴细胞亚群
CD4+T淋巴细胞
CD8+T淋巴细胞
新型冠状病毒肺炎淋巴细胞亚群与严重程度的相关分析
冠状病毒感染
肺炎,病毒性
淋巴细胞亚群
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 检测淋巴细胞内的冠状病毒RNA可作为SARS的早期诊断指标
来源期刊 中国医学检验杂志 学科 医学
关键词
年,卷(期) 2004,(3) 所属期刊栏目 论著
研究方向 页码范围 167-171
页数 5页 分类号 R373
字数 语种 中文
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (4)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2003(4)
  • 参考文献(4)
  • 二级参考文献(0)
2004(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
引文网络交叉学科
相关学者/机构
期刊影响力
中国医学检验杂志
双月刊
1606-8025
北京市2086-308信箱
chi
出版文献量(篇)
928
总下载数(次)
1
论文1v1指导